BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27

• Business

  Inspire Pharmaceuticals, Inc. Elects Alan F. Holmer to Board of Directors

  February 10, 2009

   · 

  1 min read
• Business

  Medtronic, Inc. to Announce Financial Results for Its Third Fiscal Quarter

  February 10, 2009

   · 

  1 min read
• Mikai(R) Introduces New Minimally Invasive Falena(R) Interspinous Device to Treat Common Degenerative Spinal Disorders

  February 10, 2009

   · 

  1 min read
• Biotech Bay

  Natus Medical Incorporated to Present at the Roth Capital Partners 21st Annual Growth Stock Conference

  February 10, 2009

   · 

  1 min read
• Business

  NeuroMetrix, Inc. Reports Total Revenues of $7.2 Million for the Fourth Quarter of 2008

  February 10, 2009

   · 

  1 min read
• Biotech Bay

  Oculus Innovative Sciences, Inc. to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

  February 10, 2009

   · 

  1 min read
• Policy

  OSI Pharmaceuticals, Inc. Announces Notification of ANDA Filing for Tarceva

  February 10, 2009

   · 

  1 min read
• Drug Development

  Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes Phase II Study in Patients with Impaired Glucose Tolerance Designed to Confirm Therapeutic Activity

  February 10, 2009

   · 

  3 min read
• Drug Development

  Vermillion Presents Critical Data From Its OVA1 Clinical Trial

  February 10, 2009

   · 

  6 min read
• Pharm Country

  Pfizer Inc. to Publicly Disclose Payments to U.S. Physicians, Healthcare Professionals and Clinical Investigators

  February 10, 2009

   · 

  1 min read